AGA Living Clinical Practice Guideline on Pharmacological Management of Moderate-to-Severe Ulcerative Colitis

By sjmartinez • November 22, 2024

Singh S, Loftus EV Jr, Limketkai BN, Haydek JP, Agrawal M, Scott FI, Ananthakrishnan AN; AGA Clinical Guidelines Committee. Electronic address: clinicalpractice@gastro.org. AGA Living Clinical Practice Guideline on Pharmacological Management of Moderate-to-Severe Ulcerative Colitis. Gastroenterology. 2024 Dec;167(7):1307-1343. doi: 10.1053/j.gastro.2024.10.001. PMID: 39572132.

Tags: Digestive Diseases, Evidence Synthesis, inflammatory bowel disease, Network meta-analysis, Positioning, Publications

Alcohol-Associated Hepatitis: Short- and Long-Term Management

De La Torre SA Jr, Morcos M, Saab S, Shetty A. Alcohol-Associated Hepatitis: Short- and Long-Term Management. Dig Dis Sci. 2024 Nov 22. doi: 10.1007/s10620-024-08705-1.[...]

Gastritis: Pathophysiology and Clinical Management

Fansiwala K, Lewis MS, Pisegna JR. Gastritis: Pathophysiology and Clinical Management. Am J Gastroenterol. 2024 Nov 21. doi: 10.14309/ajg.0000000000003216. Epub ahead of print. PMID: 39569875.

Distinct risk groups with different healthcare barriers and acute care use exist in the U.S. population with chronic liver disease

Wong CR, Crespi CM, Glenn B, Han SB, Macinko JA, Bastani R. Distinct risk groups with different healthcare barriers and acute care use exist in[...]